Comparison of Changes in the Lipid Profiles of Eastern Chinese Postmenopausal Women With Early-Stage Breast Cancer Treated With Different Aromatase Inhibitors: A Retrospective Study-Reference-Cited by-同舟云学术

Comparison of Changes in the Lipid Profiles of Eastern Chinese Postmenopausal Women With Early-Stage Breast Cancer Treated With Different Aromatase Inhibitors: A Retrospective Study

Published:2017-12-29 Issue:8 Volume:7 Page:837-843
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Tian Wei¹,Wu Miaowei¹,Deng Yongchuan¹

Affiliation:

1. Department of Surgical Oncology, the Second Affiliated Hospital, School of Medicine; Zhejiang University; Hangzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.420/fullpdf

Reference25 articles.

1. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial;Baum;Lancet,2002

2. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer;Coombes;N Engl J Med,2004

3. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen;Dowsett;J Clin Oncol.,2010

4. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Dowsett;Lancet.,2015

5. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years‧ adjuvant treatment for breast cancer;Howell;Lancet.,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study;International Journal of Molecular Sciences;2024-03-31

2. Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-03-21

3. Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase;ACS Pharmacology & Translational Science;2023-11-23

4. Risk of Cardiovascular Events and Lipid Profile Change in Patients with Breast Cancer Taking Aromatase Inhibitor: A Systematic Review and Meta-Analysis;Current Oncology;2023-02-02

5. Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies;Scientific Reports;2022-12-31